CU6 clarity pharmaceuticals ltd

Ann: First patient imaged in Phase III AMPLIFY trial, page-10

  1. 2,298 Posts.
    lightbulb Created with Sketch. 425
    This is plumb normal for all biotechs that dose first patient. It is classified as PS.

    its like quarterlies for pre revenue companies. They're mostly all known info but marked as PS.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.11
Change
-0.200(4.64%)
Mkt cap ! $1.329B
Open High Low Value Volume
$4.20 $4.27 $4.09 $7.447M 1.792M

Buyers (Bids)

No. Vol. Price($)
1 1000 $4.11
 

Sellers (Offers)

Price($) Vol. No.
$4.12 2000 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.